Skip to content

Cardiovascular Magnetic resonance imaging and Echocardiography in Rheumatoid Arthritis - Patterns of cardiovascular dysfunction in patients with rheumatoid arthritis.

Cardiovascular Magnetic resonance imaging and Echocardiography in Rheumatoid Arthritis - Patterns of cardiovascular dysfunction in patients with rheumatoid arthritis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21327
Enrollment
80
Registered
2012-03-02
Start date
2012-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The main study parameters will be patterns of cardiovascular dysfunction in different groups of RA patients using cardiac imaging techniques echocardiography and cardiac MRI. To assess cardiovascular

Sponsors

Medisch Spectrum Twente, Enschede, The Netherlands Department of Cardiology and Department of Rheumatology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants in this study will be selected from a large database of RA patients at the rheumatology department. Three groups of patients with rheumafactor positive and anti-CCP positive rheumatoid arthritis will be selected. The first group consists of 30 patients with new onset rheumatoid arthritis (early RA group, 6 months). The third group consists of 30 patients with longstanding rheumatoid arthritis (longstanding RA, > 15 years disease duration, erosive disease, expert based stable low disease activity > 6 months). The age of the study population is 18-75 year

Exclusion criteria

Exclusion criteria: Exclusion criteria: previous CV disease, current smoking, age 75 years, pregnancy, history of kidney dysfunction (GFR 6.5 mmol/l), history of hypertension (systolic pressure > 140 mmHg, diastolic pressure > 90 mmHg) or use of antihypertensive medication, history of diabetes mellitus (fasting glucose level > 7.0 mmol/l), body mass index > 30 kg/m2, claustrophobia or other exclusion criteria for MRI such as implanted metal materials.

Design outcomes

Primary

MeasureTime frame
With this pilot study we want to determine parameters that are useful for further follow-up studies in patient with RA in assessing cardiovascular risk with cardiac imaging techniques.

Contacts

Public ContactE.O.F. Gorselen, van

Haaksbergerstraat 55

e.vangorselen@mst.nl+31 (0)53 4872110

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)